Chinese Journal of Pharmaceuticals
|
2023, 54(5): 800-804
• Pharmaceutical Management & Information •
Challenges and Countermeasures of Chinese Medicine Enterprises under the Background of National Implementation of Collective Procurement of Proprietary Chinese Medicines
Full
Tiantian DING
1, 2, Zaixiang TAN
1, 3, *, Aibing QIAN
2
Affiliations
- 1.Health Policy and Health Management Center, Xuzhou Medical University, Xuzhou 221004
- 2.School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing 210023
- 3.Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006
Published: 2023-05-10
doi: 10.16522/j.cnki.cjph.2023.05.023
Outline
丁甜甜, 谈在祥, 钱爱兵.
国家实施中成药集采背景下中药企业的挑战与应对.
中国医药工业杂志,
2023
, 54
(5)
: 800
-804
.
DOI: 10.16522/j.cnki.cjph.2023.05.023
Tiantian DING, Zaixiang TAN, Aibing QIAN.
Challenges and Countermeasures of Chinese Medicine Enterprises under the Background of National Implementation of Collective Procurement of Proprietary Chinese Medicines[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(5)
: 800
-804
.
DOI: 10.16522/j.cnki.cjph.2023.05.023
Year 2023 volume 54 Issue 5
34
11
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.05.023
- Receive Date:2022-10-31
- Online Date:2026-11-19
- Published:2023-05-10